lipoxin a4 has been researched along with Spinal Cord Injuries in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Liu, J; Peng, L | 1 |
| Dong, Y; Duan, Y; Liu, X; Lu, T; Shang, C; Wei, N; Wu, X; Zhou, Y | 1 |
| Bento, AF; Berta, T; Chen, G; Forner, S; Ji, RR; Martini, AC; Rae, GA | 1 |
3 other study(ies) available for lipoxin a4 and Spinal Cord Injuries
| Article | Year |
|---|---|
The Lipoxin A4 Receptor Agonist BML-111 Alleviates Inflammatory Injury and Oxidative Stress in Spinal Cord Injury.
Topics: Animals; Apoptosis; Heptanoic Acids; Inflammation; Interleukin-1beta; Interleukin-6; Lipoxins; Male; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Receptors, Lipoxin; Spinal Cord; Spinal Cord Injuries; Tumor Necrosis Factor-alpha | 2020 |
Lipoxin A4 protects against spinal cord injury via regulating Akt/nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 signaling.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromones; Disease Models, Animal; Gene Expression Regulation; Heme Oxygenase-1; Lipoxins; Male; Morpholines; Neuroprotective Agents; NF-E2-Related Factor 2; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Cord Injuries | 2018 |
Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection.
Topics: Animals; Axotomy; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Inflammation; Injections, Spinal; Lipoxins; Male; Mice; Microglia; Neuralgia; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Spinal Cord Injuries | 2016 |